Back to the main directory
Company Analysis / Equity
- Crude-Market Fundamentals Continue to Tighten, but the Recovery Still Has a Ways to Go by Morningstar
- Project Delays Affect U.S. Ecology’s Third-Quarter Results; Shares Fairly Valued by Morningstar
- CSC Continues its Shift to the Next-Generation; GIS Headwinds Remain; Shares Moderately Overvalued by Morningstar
- Relaunching Coverage of Garmin with Narrow Economic Moat, Negative Trend, and $48 FVE by Morningstar
- Ross posts very strong market share gains, demonstrating that its narrow moat is intact. by Morningstar
- UBS Reports Mixed Third Quarter, Boosts Legal Provisions by Morningstar
- Enbridge/Spectra Energy Merger, Maintaining SEP Fair Value Estimate and Wide Moat Rating by Morningstar
- ARX Reports Third-Quarter Results; Raising Fair Value Estimate by Morningstar
- OPEC Cuts, U.S. E&Ps Drill: Our Oil Price Outlook Remains Unchanged by Morningstar
- CCCC's 1H Result In Line; Margin Expansion and Accelerating Top-Line Growth On Track in 2H by Morningstar
- Inditex Posts Strong First-Half Performance; Like-for-Like Sales Growth Defying Industry Headwinds by Morningstar
- Noble Group Continues to See Operating Cash Outflow; No Change in FVE by Morningstar
- Samsung Electronics to Return Future Surplus Cash to Shareholders by Morningstar
- The most profitable Shinkansen route also means the largest capital spending in the future. by Morningstar
- Kinder Morgan Misses Third-Quarter Expectations; Deleveraging and Growth Ahead of Schedule by Morningstar
- Chorus Travels Across the Tasman to Land New Boss by Morningstar
- RBI Navigating Tough North American Trends, but International Growth and Profitability Intact by Morningstar
- Aetna will strengthen its advantages if it can acquire Humana, but we believe the firm overpaid. by Morningstar
- CCU's narrow economic moat is intact, but cyclical challenges will temper near-term results. by Morningstar
- Schnitzer's operating margins will remain in the low-single-digits through the end of the decade. by Morningstar
- Primary benefits from defensive diagnostics earnings and upside from increased medical centre usage. by Morningstar
- Melco Crown’s FVE Maintained at USD 17.00 Per Share; Studio City Ramped Up Faster in Q3 by Morningstar
- Industrials After Trump's Election: Greater Uncertainty but Defense Likely the Greatest Beneficiary by Morningstar
- Resilience of Melbourne Underpins Crown Resorts' Solid Result; FVE Eased to AUD 14.50 by Morningstar
- Hurricane Matthew Impact Should Be Manageable for our P&C Insurance Coverage by Morningstar